Glycans on influenza hemagglutinin affect receptor binding and immune response

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 43, 2009, Pages 18327-18332

  Wang, Cheng Chi ^a,d   Chen, Juine Ruey ^a,e   Tseng, Yung Chieh ^a   Hsu, Che Hsiung ^a,b,f   Hung, Yu Fu ^a   Chen, Shih Wei ^a   Chen, Chin Mei ^c   Khoo, Kay Hooi ^c   Cheng, Ting Jen ^a   Cheng, Yih Shyun E ^a   Jan, Jia Tsrong ^a   Wu, Chung Yi ^a   Ma, Che ^a   Wong, Chi Huey ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Flu vaccine; Glycan binding; Glycosylation

Indexed keywords

GLYCAN; GLYCINE; GLYCOPROTEIN; HEMAGGLUTININ FG; HEMAGGLUTININ MG; INFLUENZA VIRUS HEMAGGLUTININ; LIGAND; MONOSACCHARIDE; NEUTRALIZING ANTIBODY; SIALIC ACID; SULFATE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; EMBRYO; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS A H5N1; LIGAND BINDING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; RECEPTOR BINDING; VIRUS IMMUNITY;

AVES; FLU VACCINE; SUIDAE;

EID: 70849130101     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905815106     Document Type: Article

References (39)

1. Garten RJ, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
2. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931-939.
3. Kuiken T, et al. (2006) Host species barriers to influenza virus infections. Science 312:394-397.
4. Maines TR, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484-487.
5. Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem 69:531-569.
6. van Riel D, et al. (2006) H5N1 virus attachment to lower respiratory tract. Science 312:399-399
7. Connor RJ, Kawaoka Y, Webster RG, Paulson JC (1994) Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205:17-23. (Pubitemid 24360586)
8. Tumpey TM, et al. (2007) A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659.
9. Keil W, et al. (1985) Carbohydrates of influenza-virus-structural elucidation of the individual glycans of the FPV hemagglutinin by two-dimensional H-1 NMR and methylation analysis. EMBO J 4:2711-2720.
10. Chen ZY, Aspelund A, Jin H (2008) Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs. Vaccine 26:361-371.
11. Ohuchi R, Ohuchi M, Garten W, Klenk HD (1997) Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity. J Virol 71:3719-3725. (Pubitemid 27172384)
12. Skehel JJ, et al. (1984) A carbohydrate side-chain on hemagglutinins of Hong Kong influenza-viruses inhibits recognition by a monoclonal-antiboby. Proc Natl Acad Sci USA 81:1779-1783.
13. Deshpande KL, Fried VA, Ando M, Webster RG (1987) Glycosylation affects cleavage of an H5N2 influenza-virus hemagglutinin and regulates virulence. Proc Natl Acad Sci USA 84:36-40. (Pubitemid 17013573)
14. Gunther I, Glatthaar B, Doller G, Garten W (1993) A H1-hemagglutinin of a human influenza A-virus with a carbohydrate-modulated receptor-binding site and an unusual cleavage site. Virus Res 27:147-160. (Pubitemid 23055737)
15. Blixt O, et al. (2004) Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 101:17033-17038. (Pubitemid 39627769)
16. Chandrasekaran A, et al. (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26:107-113.
17. Liang PH, Wang SK, Wong CH (2007) Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: Determination of surface and solution dissociation constants. J Am Chem Soc 129:11177-11184.
18. Stevens J, et al. (2008) Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol 381:1382-1394.
19. Srinivasan A, et al. (2008) Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc Natl Acad Sci USA 105:2800-2805. (Pubitemid 351723624)
20. Deom CM, Caton AJ, Schulze IT (1986) Host cell-mediated selection of a mutant influenza Avirus that has lost a complex oligosaccharide from the tip of the hemagglutinin. Proc Natl Acad Sci USA 83:3771-3775.
21. Chen MW, et al. (2008) A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci USA 105:13538-13543.
22. Wang CC, et al. (2008) Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci USA 105:11661-11666.
23. Sauter NK, et al. (1989) Hemagglutinins from 2 influenza-virus variants bind to sialic-acid derivatives with millimolar dissociation-constants - A 500-MHz proton nuclear magnetic-resonance study. Biochemistry 28:8388-8396.
24. Hanson SR, et al. (2009) The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. Proc Natl Acad Sci USA 106:3131-3136.
25. Wagner R, Heuer D, Wolff T, Herwig A, Klenk HD (2002) N-glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. J Gen Virol 83:601-609. (Pubitemid 34183005)
26. Vigerust DJ, et al. (2007) N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 81:8593-8600. (Pubitemid 47242833)
27. Hoffmann E, Lipatov AS, Webby RJ, Govorkova EA, Webster RG (2005) Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc Natl Acad Sci USA 102:12915-12920. (Pubitemid 41279464)
28. Huleatt JW, et al. (2008) Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26:201-214.
29. Scanlan CN, et al. (2007) Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. J Mol Biol 372:16-22.
30. Yang ZY, et al. (2007) Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317:825-828.
31. Ekiert DC, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
32. Kashyap AK, et al. (2008) Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci USA 105:5986-5991.
33. Scheid JF, et al. (2009) Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458:636-640.
34. Stevens J, et al. (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.
35. Sui JH, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16:265-273.
36. Throsby M, et al. (2008) Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM memory B cells. PLoS ONE 3:e3942.
37. Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N- acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci USA 99:13419-13424. (Pubitemid 35215396)
38. Wei CJ, et al. (2008) Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 82:6200-6208.
39. Bohne-Lang A, von der Lieth CW (2005) GlyProt: In silico glycosylation of proteins. Nucleic Acids Res 33:W214-W219.